Article Information
History
- October 10, 2020.
Article Versions
- Version 1 (October 8, 2020 - 06:56).
- You are currently viewing Version 2 of this article (October 10, 2020 - 04:32).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- 1Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Ontario, M5G2C1, Canada
- 2Raymond G. Perelman Center for Cellular and Molecular Therapeutics, Children’s Hospital of Philadelphia, Philadelphia, PA 19104, USA
- 3Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
- ↵*To whom correspondence should be addressed: Dr. Kai Wang, Tel: +1 267 425 9573; Fax: +1 215 590 3660; Email: wangk{at}email.chop.edu Correspondence may also be addressed to Dr. Quan Li, Tel: +1 416 634 8721; Email: leequan{at}gmail.com;